Comparison Of Rocuronium Reversal By Sugammadex To Succinylcholine For Electroconvulsive Therapy (ECT)
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California
- Dates
- study startedestimated completion
- Principal Investigator
- by Chanhung Lee, MD, PhD
Description
Summary
Official Title
Details
Keywords
Eligibility
Location
Lead Scientist at UCSF
- Chanhung Lee, MD, PhD
Professor, Anesthesia. Authored (or co-authored) 15 research publications.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, San Francisco
- ID
- NCT03532178
- Phase
- Phase 2
- Study Type
- Interventional
- Last Updated